Oxford Live 2022

Published: 20 September 2022

  • Views:

    Views Icon 2426
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

Now in its twelfth year, Oxford Live 2022, held on 1 September, was a case-based meeting combining coronary and structural live case transmissions from John Radcliffe Hospital, Oxford, with lecture presentations from national and international faculty. 

 

The conference was led by course director and consultant cardiologist Prof Adrian Banning (John Radcliffe Hospital, UK).

 

This on-demand version of the programme is aimed at cardiologists, cardiac surgeons, specialist registrars and allied health professionals involved in caring for cardiac patients. 

Oxford Live 2022 is supported by Boston Scientific.

Key Learning Objectives

  • To understand the management of coronary disease in patients with aortic stenosis
  • To understand the role of imaging in pre and post assessment of coronary disease and its management
  • To understand the influence of calcium on outcomes of coronary intervention and how to optimise patient outcomes

Target Audience

  • Cardiologists
  • Cardiac surgeons
  • Specialist registrars
  • Allied health professionals involved in caring for cardiac patients

More from this programme

Faculty Biographies

Jeremy  Langrish

Jeremy Langrish

Interventional Cardiologist

Dr Jeremy Langrish is an interventional cardiologist at the John Radcliffe Hospital and has extensive experience in cardiac catheterisation, PCI and intravascular imaging. He has a background in clinical research and a strong interest in vascular biology and mechanisms of vascular dysfunction.

View full profile
Keith  Channon

Keith Channon

Professor of Cardiovascular Medicine

Prof Keith Channon is the Chief Investigator of OxAMI. He is Professor of Cardiovascular Medicine at Oxford University and an Interventional Cardiologist at the John Radcliffe Hospital. He has extensive experience in Percutaneous Coronary Intervention (PCI ) and intravascular imaging and in atherosclerotic plaque and vascular biology.

Prof Channon is Director of R&D at Oxford University Hospitals NHS Trust and Director of the NIHR Oxford Biomedical Research Centre.

View full profile